Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
This controlled release injectable formulation is proven to aid in sustained weight loss
Specifically, the co-administration led to a reduction in HbA1c levels by 2.2 percentage points
The compound received marketing approval in China in June 2025 under the brand name Xinermei, making it the first domestically approved dual GLP-1/glucagon agonist anywhere in the world
Another important aspect is the cost and accessibility of the medication
Spray Administration Follow proper technique for using the nasal spray, including priming the pump, aiming the spray towards the nasal cavity, and ensuring no inhalation through the nose during administration
As your dosage increases, you may notice stronger appetite-suppressing and metabolic effects, which can further support your weight loss journey
US$ 23.87
US$ 27.97
US$ 20.34
US$ 27.46
US$ 20.78
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
